Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, CA, 92093-0507, USA.
Department of Psychology, San Diego State University, San Diego, CA, USA.
Subst Abuse Treat Prev Policy. 2022 May 19;17(1):39. doi: 10.1186/s13011-022-00470-6.
Evidence suggests people who inject drugs (PWID) prescribed opioid agonist treatment (OAT) are less likely to provide injection drug use (IDU) initiation assistance. We investigated the association between OAT engagement and providing IDU initiation assistance across poly-drug use practices in Vancouver, Canada.
Preventing Injecting by Modifying Existing Responses (PRIMER) is a prospective study seeking to identify structural interventions that reduce IDU initiation. We employed data from linked cohorts of PWID in Vancouver and extended the findings of a latent profile analysis (LPA). Multivariable logistic regression models were performed separately for the six poly-drug use LPA classes. The outcome was recently assisting others in IDU initiation; the independent variable was recent OAT engagement.
Among participants (n = 1218), 85 (7.0%) reported recently providing injection initiation assistance. When adjusting for age and sex, OAT engagement among those who reported a combination of high-frequency heroin and methamphetamine IDU and low-to-moderate-frequency prescription opioid IDU and methamphetamine non-injection drug use (NIDU) was associated with lower odds of IDU initiation assistance provision (Adjusted Odds Ratio [AOR]: 0.18, 95% CI: 0.05-0.63, P = 0.008). Significant associations were not detected among other LPA classes.
Our findings extend evidence suggesting that OAT may provide a population-level protective effect on the incidence of IDU initiation and suggest that this effect may be specific among PWID who engage in high-frequency methamphetamine and opioid use. Future research should seek to longitudinally investigate potential causal pathways explaining the association between OAT and initiation assistance provision among PWID to develop tailored intervention efforts.
有证据表明,接受阿片类激动剂治疗(OAT)的吸毒者(PWID)不太可能提供注射吸毒(IDU)起始协助。我们调查了在加拿大温哥华,OAT 参与情况与提供 IDU 起始协助之间的关系,同时考虑了多种药物使用行为。
预防注射行为改变现有反应(PRIMER)是一项前瞻性研究,旨在确定减少 IDU 起始的结构干预措施。我们利用温哥华吸毒者的关联队列数据,并扩展了潜在剖面分析(LPA)的发现。针对六种多药物使用 LPA 类别分别进行多变量逻辑回归模型分析。结局是最近协助他人进行 IDU 起始;自变量是最近的 OAT 参与情况。
在参与者(n=1218)中,有 85 人(7.0%)报告最近提供了注射起始协助。在调整年龄和性别后,报告高频海洛因和冰毒 IDU 以及低至中度频率处方类阿片药物 IDU 和冰毒非注射药物使用(NIDU)组合的参与者中,OAT 参与与提供 IDU 起始协助的可能性较低相关(调整后的优势比 [AOR]:0.18,95%CI:0.05-0.63,P=0.008)。在其他 LPA 类别中未发现显著关联。
我们的研究结果扩展了证据,表明 OAT 可能对 IDU 起始的发生率产生人群水平的保护作用,并表明这种作用可能在高频使用冰毒和阿片类药物的 PWID 中更为具体。未来的研究应寻求对 OAT 与 PWID 起始协助提供之间的关联进行潜在因果途径的纵向调查,以制定有针对性的干预措施。